Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacqueline Cloos

Showing results (91-100 of 172) with videos related to

Pageof 18
Sort By:
Leukemia|July 17, 2021
Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemiaInge van der Werf, Anna Wojtuszkiewicz, Huilan Yao, et al.
Plos One|February 8, 2011
Down-regulation of miR-101 in endothelial cells promotes blood vessel formation through reduced repression of EZH2Michiel Smits, Shahryar E Mir, R Jonas A Nilsson, et al.
Haematologica|September 24, 2013
Higher ratio immune versus constitutive proteasome level as novel indicator of sensitivity of pediatric acute leukemia cells to proteasome inhibitorsDenise Niewerth, Niels E Franke, Gerrit Jansen, et al.
International Journal of Biological Sciences|June 21, 2024
Exploring Splicing Modulation as an Innovative Approach to Combat Pancreatic Cancer: SF3B1 Emerges as a Prognostic Indicator and Therapeutic TargetRocco Sciarrillo, Francesca Terrana, Annalisa Comandatore, et al.
Plos One|June 8, 2012
High accuracy mutation detection in leukemia on a selected panel of cancer genesZeynep Kalender Atak, Kim De Keersmaecker, Valentina Gianfelici, et al.
Plos Genetics|December 25, 2013
Comprehensive analysis of transcriptome variation uncovers known and novel driver events in T-cell acute lymphoblastic leukemiaZeynep Kalender Atak, Valentina Gianfelici, Gert Hulselmans, et al.
Cancers|May 21, 2020
Harnessing Gene Expression Profiles for the Identification of Ex Vivo Drug Response Genes in Pediatric Acute Myeloid LeukemiaDavid G J Cucchi, Costa Bachas, Marry M van den Heuvel-Eibrink, et al.
Blood Advances|September 15, 2021
DNA vs cDNA FLT3-ITD allelic ratio and length measurements in adult acute myeloid leukemiaDavid G J Cucchi, Christian M Vonk, Melissa Rijken, et al.
Investigational New Drugs|February 15, 2018
Proteasome inhibition and mechanism of resistance to a synthetic, library-based hexapeptideRuud Oerlemans, Celia R Berkers, Yehuda G Assaraf, et al.
Leukemia|August 21, 2024
Optimal prognostic threshold for measurable residual disease positivity by multiparameter flow cytometry in acute myeloid leukemia (AML)Eduardo Rodríguez-Arbolí, Megan Othus, Sylvie D Freeman, et al.
Pageof 18

Showing results (91-100 of 172) with videos related to

Sort By:
Pageof 18
Leukemia|July 17, 2021
Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemiaInge van der Werf, Anna Wojtuszkiewicz, Huilan Yao, et al.
Plos One|February 8, 2011
Down-regulation of miR-101 in endothelial cells promotes blood vessel formation through reduced repression of EZH2Michiel Smits, Shahryar E Mir, R Jonas A Nilsson, et al.
Haematologica|September 24, 2013
Higher ratio immune versus constitutive proteasome level as novel indicator of sensitivity of pediatric acute leukemia cells to proteasome inhibitorsDenise Niewerth, Niels E Franke, Gerrit Jansen, et al.
International Journal of Biological Sciences|June 21, 2024
Exploring Splicing Modulation as an Innovative Approach to Combat Pancreatic Cancer: SF3B1 Emerges as a Prognostic Indicator and Therapeutic TargetRocco Sciarrillo, Francesca Terrana, Annalisa Comandatore, et al.
Plos One|June 8, 2012
High accuracy mutation detection in leukemia on a selected panel of cancer genesZeynep Kalender Atak, Kim De Keersmaecker, Valentina Gianfelici, et al.
Plos Genetics|December 25, 2013
Comprehensive analysis of transcriptome variation uncovers known and novel driver events in T-cell acute lymphoblastic leukemiaZeynep Kalender Atak, Valentina Gianfelici, Gert Hulselmans, et al.
Cancers|May 21, 2020
Harnessing Gene Expression Profiles for the Identification of Ex Vivo Drug Response Genes in Pediatric Acute Myeloid LeukemiaDavid G J Cucchi, Costa Bachas, Marry M van den Heuvel-Eibrink, et al.
Blood Advances|September 15, 2021
DNA vs cDNA FLT3-ITD allelic ratio and length measurements in adult acute myeloid leukemiaDavid G J Cucchi, Christian M Vonk, Melissa Rijken, et al.
Investigational New Drugs|February 15, 2018
Proteasome inhibition and mechanism of resistance to a synthetic, library-based hexapeptideRuud Oerlemans, Celia R Berkers, Yehuda G Assaraf, et al.
Leukemia|August 21, 2024
Optimal prognostic threshold for measurable residual disease positivity by multiparameter flow cytometry in acute myeloid leukemia (AML)Eduardo Rodríguez-Arbolí, Megan Othus, Sylvie D Freeman, et al.
Pageof 18